Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Radiation Injuries 4Medulloblastoma 3Choroid Plexus Neoplasms 3Central Nervous System Neoplasms 3Brain Neoplasms 3Astrocytoma 3Pinealoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2Meningioma 2Gliosarcoma 2Glioma, Subependymal 2Glioma 2Glioblastoma 2Fatigue 2Ependymoma 2Depression 2Craniopharyngioma 2Cognitive Dysfunction 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Retention 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sleep Wake Disorders 1Pain 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Neuropsychological Tests 4Walking 3Memantine 3Tablets 2Standard of Care 2Patient Reported Outcome Measures 2Methods 2Electroencephalography 2Drug Therapy 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lithium sulfate 1lime 1fasudil 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1XENP 1595 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Donepezil × Clear all
NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed
276 enrolled 33 charts
Breast

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

NCT00594633 2016-01-14

Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
25 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡